Does ENZALUTAMIDE Cause Prostate cancer? 642 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 642 reports of Prostate cancer have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.3% of all adverse event reports for ENZALUTAMIDE.
642
Reports of Prostate cancer with ENZALUTAMIDE
1.3%
of all ENZALUTAMIDE reports
243
Deaths
106
Hospitalizations
How Dangerous Is Prostate cancer From ENZALUTAMIDE?
Of the 642 reports, 243 (37.9%) resulted in death, 106 (16.5%) required hospitalization, and 7 (1.1%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 642 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
RITUXIMAB (317)
Which ENZALUTAMIDE Alternatives Have Lower Prostate cancer Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE